出典: meddic


Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/02/24 13:15:49」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.


  • Degree of mucositis and duration of neutropenia are the major risk factors for early post-transplant febrile neutropenia and severe bacterial infections after reduced-intensity conditioning.
  • Facchini L, Martino R, Ferrari A, Piñana JL, Valcárcel D, Barba P, Granell M, Delgado J, Briones J, Sureda A, Brunet S, Sierra J.SourceHematology Department of the Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • European journal of haematology.Eur J Haematol.2012 Jan;88(1):46-51. doi: 10.1111/j.1600-0609.2011.01724.x.
  • Background and objectives: Whether the intensity of the conditioning regimen affects febrile neutropenia (FN) and severe bacterial infections (SBIs) is not well established. We analyzed the risk factors (RFs) for the development of FN and SBI in the first 100 d post-transplant in 195 consecutive a
  • PMID 22023368
  • Weight-based strategy of dose administration in children using intravenous busulfan: Clinical and pharmacokinetic results.
  • Michel G, Valteau-Couanet D, Gentet JC, Esperou H, Socié G, Méchinaud F, Doz F, Neven B, Bertrand Y, Galambrun C, Demeocq F, Yakouben K, Bordigoni P, Frappaz D, Nguyen L, Vassal G.SourcePediatric Hematology, Hopital Enfants Timone, Marseille, France.
  • Pediatric blood & cancer.Pediatr Blood Cancer.2012 Jan;58(1):90-7. doi: 10.1002/pbc.22959. Epub 2011 Jan 19.
  • BACKGROUND: A prospective clinical trial was performed in order to validate the pharmacokinetic (PK) and clinical benefits of a new dosing schedule of intravenous busulfan (IV Bu) in children.PROCEDURE: IV Bu was administered as a 2-hr infusion every 6 hr for 4 days. Five dose levels were given ac
  • PMID 21254374


  • Localization of a novel RNA-binding protein, SKIV2L2, to the nucleus in the round spermatids of mice
  • Osman Boran A. H.,Kawashima Akihiro,Tamba Michiko [他]
  • The journal of reproduction and development 57(4), 457-467, 2011-08
  • NAID 40018970922
  • Localization of a Novel RNA-binding Protein, SKIV2L2, to the Nucleus in the Round Spermatids of Mice
  • OSMAN Boran A.H.,KAWASHIMA Akihiro,TAMBA Michiko,SATOH Emiko,KATO Yuhki,IKI Ayumi,KONISHI Kouhei,MATSUDA Manabu,OKAMURA Naomichi
  • Journal of Reproduction and Development advpub(0), 1104010363, 2011
  • … 80: 1293-1304), we suggested that the first cycle of spermatogenesis recovered from busulfan-induced temporary arrest was a good model system to analyze the proteins expressed at the specific stages of spermatogenesis in the mouse, and this has been confirmed in the present paper. … Namely, six-week-old mice were injected with busulfan at 20 mg/kg body weight. …
  • NAID 130000677047


ブスルファン (Busulfan) は、アルキル化剤に分類される抗悪性腫瘍剤(抗がん剤)で ある。日本では協和発酵キリンからブスルフェクス点滴静注用の商品名で、大原薬品 工業からマブリン散の商品名で製造販売されている。ブスルフェクス点滴静注用は造血 ...
Busulfan (Myleran, GlaxoSmithKline, Busulfex IV, PDL BioPharma, Inc.) is a cancer drug, in use since 1959. Busulfan is a cell cycle non-specific alkylating antineoplastic agent, in the class of alkyl sulfonates. Its chemical designation is 1 ...


Antitumour Antibiotics (Antineoplastics):Busulfan, Myleran, Mysulfan | Buy Busulfan Myleran prescription drug /side effects Pathway Busulfan Pathway, PharmacodynamicsBusulfan-Myleran-2mg-00221-1busulfan review buy busulfan busulfan is a




busulfan busulphan BUS
ミレラン Myleranブスルフェクスマブリン
  • アルキル化薬
  • alkyl sulfonate
  • chronic myelogenous leukemia